114 related articles for article (PubMed ID: 2684300)
21. ras p21 immunohistochemical detection in human endometrial carcinomas.
Semczuk A; Miturski R; Baranowski W; Jakowicki JA
Gynecol Obstet Invest; 1997; 44(2):132-5. PubMed ID: 9286729
[TBL] [Abstract][Full Text] [Related]
22. Specific effects of ras oncogene expression on the growth and histogenesis of human epidermal keratinocytes.
Henrard DR; Thornley AT; Brown ML; Rheinwald JG
Oncogene; 1990 Apr; 5(4):475-81. PubMed ID: 2183155
[TBL] [Abstract][Full Text] [Related]
23. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
[TBL] [Abstract][Full Text] [Related]
24. Sulindac sulfide inhibits Ras signaling.
Herrmann C; Block C; Geisen C; Haas K; Weber C; Winde G; Möröy T; Müller O
Oncogene; 1998 Oct; 17(14):1769-76. PubMed ID: 9778042
[TBL] [Abstract][Full Text] [Related]
25. [Localization of oncoprotein P21ras in the human liver cancer].
Hong JX; Wei MH; Zhang X; Liu YW; Wan DF; Gu JR; Yu XS; Shi DR; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):81-4. PubMed ID: 3308383
[TBL] [Abstract][Full Text] [Related]
26. Isolation of azatyrosine-induced revertants from ras-transformed human mammary epithelial cells.
Kyprianou N; Taylor-Papadimitriou J
Oncogene; 1992 Jan; 7(1):57-63. PubMed ID: 1741165
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling reveals consistent differences between clinical samples of human leukaemias and their model cell lines.
Leupin N; Kuhn A; Hügli B; Grob TJ; Jaggi R; Tobler A; Delorenzi M; Fey MF
Br J Haematol; 2006 Nov; 135(4):520-3. PubMed ID: 17061979
[TBL] [Abstract][Full Text] [Related]
28. Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy.
Chesa PG; Rettig WJ; Melamed MR; Old LJ; Niman HL
Proc Natl Acad Sci U S A; 1987 May; 84(10):3234-8. PubMed ID: 3554234
[TBL] [Abstract][Full Text] [Related]
29. Activation of p21ras is not sufficient to ensure a complete G1 phase of the cell division cycle in mouse fibroblasts.
Gaben AM; Saucier C; Bedin M; Barbu V; Courilleau D; Bon-Hoa DH; Mester J
Oncogene; 1996 Nov; 13(10):2113-20. PubMed ID: 8950978
[TBL] [Abstract][Full Text] [Related]
30. Involvement of p21ras in activation of extracellular signal-regulated kinase 2.
de Vries-Smits AM; Burgering BM; Leevers SJ; Marshall CJ; Bos JL
Nature; 1992 Jun; 357(6379):602-4. PubMed ID: 1608472
[TBL] [Abstract][Full Text] [Related]
31. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines.
Liou JS; Chen JS; Faller DV
J Cell Physiol; 2004 Feb; 198(2):277-94. PubMed ID: 14603530
[TBL] [Abstract][Full Text] [Related]
32. Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes.
Delage S; Chastre E; Empereur S; Wicek D; Veissiére D; Capeau J; Gespach C; Cherqui G
Cancer Res; 1993 Jun; 53(12):2762-70. PubMed ID: 8504416
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of p21ras upon T-cell activation.
Downward J; Graves JD; Warne PH; Rayter S; Cantrell DA
Nature; 1990 Aug; 346(6286):719-23. PubMed ID: 2201921
[TBL] [Abstract][Full Text] [Related]
34. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
[TBL] [Abstract][Full Text] [Related]
35. p21ras: an oncoprotein functioning in growth factor-induced signal transduction.
Bos JL
Eur J Cancer; 1995; 31A(7-8):1051-4. PubMed ID: 7576990
[TBL] [Abstract][Full Text] [Related]
36. [Oncogenic activation of p21(ras) and pp60(c-src) in human colonic Caco-2 cells decreases insulin receptor function and expression through protein kinase C-dependent and independent pathways].
Baron-Delage S; Barbu V; Bertrand F; Chastre E; Lévy P; Gespach C; Capeau J; Cherqui G
Bull Cancer; 1994 Oct; 81(10):882-5. PubMed ID: 7734771
[TBL] [Abstract][Full Text] [Related]
37. Contrasting levels of p21ras activation and expression of neurofibromin in peripheral primitive neuroectodermal tumour and neuroblastoma cells, and their response to retinoic acid.
Burchill SA; Berry PA; Bradbury FM; Lewis IJ
J Neurol Sci; 1998 May; 157(2):129-37. PubMed ID: 9619634
[TBL] [Abstract][Full Text] [Related]
38. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Slagle BL; Kaufman RH; Reeves WC; Icenogle JP
Cancer; 1998 Oct; 83(7):1401-8. PubMed ID: 9762942
[TBL] [Abstract][Full Text] [Related]
39. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
Matarazzo M; Faraggiana T; Donato MF; Paronetto F
J Exp Pathol; 1987; 3(3):305-15. PubMed ID: 2835467
[TBL] [Abstract][Full Text] [Related]
40. Low molecular weight GTP-binding proteins in hepatocytes and an assessment of the role of p21ras proteins in the activation of phospholipase D.
Hurst KM; Chataway TK; Hughes BP; Barritt GJ
Biochem Int; 1991 Jun; 24(3):507-16. PubMed ID: 1772429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
